Mark Anthony Fernance Kendall

Title: Mark Anthony Fernance Kendall: Innovator in Biodevice Technology

Introduction

Mark Anthony Fernance Kendall is a prominent inventor based in Chelmer, Australia. He has made significant contributions to the field of biomedical devices, particularly in the area of drug delivery systems. With a total of 17 patents to his name, Kendall's work focuses on innovative solutions for delivering materials to biological subjects.

Latest Patents

Kendall's latest patents include a delivery device designed for the efficient delivery of material to a biological subject. This device features a base with multiple projections that penetrate tissue, with at least one projection coated in a non-liquid material. The design allows for the effective delivery of substances to the dermal layer, enhancing the precision of treatment. Another notable patent is for microprojection arrays that improve skin penetration properties. This apparatus includes a microprojection array with a high density of projections, enabling the delivery of active ingredients into the skin at a defined depth.

Career Highlights

Throughout his career, Kendall has worked with notable organizations such as Vaxxas Pty Limited and The University of Queensland. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.

Collaborations

Kendall has collaborated with esteemed colleagues, including Michael Lawrence Crichton and Xianfeng Chen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biomedical innovation.

Conclusion

Mark Anthony Fernance Kendall stands out as a leading inventor in the realm of biodevice technology. His innovative patents and collaborations reflect his commitment to advancing medical solutions for better healthcare outcomes.